Addiction involves lasting changes to brain circuits controlling motivation and habit: drug-induced dopamine surges strengthen cue-reward associations (learning), activate habit circuits (basal ganglia), and suppress prefrontal control. Tolerance develops as receptors downregulate and dopamine signaling habituates. Withdrawal reflects a hypodopaminergic state. Recovery requires either time-dependent circuit remodeling or therapy-induced prefrontal strengthening to override persistent drug-related memories.
You already understand that the mesolimbic dopamine pathway encodes reward prediction and surprise — specifically that phasic dopamine bursts from the VTA to the nucleus accumbens function as a teaching signal, strengthening associations between cues and outcomes. You also know from your study of LTP that synaptic strengthening — AMPA receptor insertion, spine enlargement, increased synaptic efficacy — is the physical substrate of learning. Addiction hijacks both systems simultaneously, producing a pathologically durable form of learning that outlasts the positive experience that created it.
Addictive drugs produce dopamine surges far exceeding those generated by natural rewards. Where food or social interaction might transiently raise nucleus accumbens dopamine by 100–200% above baseline, cocaine, amphetamine, or opioids drive it to 400–1,000%. This is not simply a stronger pleasure signal — it is a learning signal of extreme magnitude applied repeatedly to the same circuits. The VTA-to-accumbens and VTA-to-prefrontal projections undergo LTP-like structural changes: AMPA receptors are inserted at synapses, dendritic spines enlarge, and the circuit becomes hyperresponsive. The environment surrounding drug use — particular places, objects, people, times of day — becomes a set of conditioned stimuli with enormous motivational salience, capable of driving powerful craving and approach behavior even before any drug is present.
Tolerance reflects a compensatory homeostatic response to chronic overstimulation. Persistent high dopamine levels cause dopamine receptors (D1, D2) to downregulate — both reducing receptor density and decreasing receptor sensitivity. This applies not just to drug-stimulated circuits but to dopamine signaling broadly: food, relationships, and achievement become subjectively flat because the system responding to natural rewards is the same one that has been recalibrated downward. The individual is no longer chasing the original high; they are trying to escape a persistent anhedonic baseline in which normal activities fail to generate sufficient dopamine signal for ordinary hedonic experience. The basal ganglia habit circuits, which you studied as a system for automating goal-directed behavior into stimulus-response sequences, become strongly engaged: drug-seeking transitions from a goal-directed behavior under prefrontal control to a habitual behavior driven by environmental cues and basal ganglia automaticity.
Withdrawal is the acute manifestation of the downregulated baseline — the drug's absence reveals the deficit rather than causing it. Meanwhile, the prefrontal cortex, which normally exerts top-down inhibitory control over the accumbens and basal ganglia, is progressively impaired: receptor downregulation and structural changes in prefrontal-striatal connectivity reduce the capacity for deliberate impulse inhibition, making voluntary control increasingly difficult as addiction progresses. This is why willpower-based models misrepresent the biology — the circuits responsible for deliberate control are the ones most compromised. Recovery involves restoring dopamine baseline through time-dependent receptor upregulation, or actively rebuilding prefrontal-striatal inhibitory connectivity through cognitive-behavioral interventions — essentially recruiting LTP mechanisms in prefrontal circuits to compete with the deeply consolidated drug-related memories in the accumbens and striatum.
No topics depend on this one yet.